720-777-0123
- Doctors & Departments
-
Conditions & Advice
- Overview
- Conditions and Symptoms
- Is Your Child Sick?
- Parent Resources
- The Connection Journey
- Calm A Crying Baby
- Sports Articles
- Dosage Tables
- Baby Guide
-
Your Visit
- Overview
- Prepare for Your Visit
- Your Overnight Stay
- Send a Cheer Card
- Family and Patient Resources
- Patient Cost Estimate
- Insurance and Financial Resources
- Online Bill Pay
- Medical Records
- Policies and Procedures
- We Ask Because We Care
Click to find the locations nearest youFind locations by region
See all locations -
Community
- Overview
- Addressing the Youth Mental Health Crisis
- Calendar of Events
- Child Health Advocacy
- Community Health
- Community Partners
- Corporate Relations
- Global Health
- Patient Advocacy
- Patient Stories
- Pediatric Affiliations
- Support Children’s Colorado
- Specialty Outreach Clinics
Your Support Matters
Upcoming Events
Nursing Excellence Awards
Wednesday, October 4, 2023RSVP for Children's Hospital Colorado Nursing Excellence Awards.
- Research & Innovation
VALIANT (Apellis 310)
January 27, 2023
- Diagnosis
- Complement 3 Glomerulopathy(C3G) or Immune-complex mediated membranoproliferative glomerulonephritis (IC-MPGN)
- Age
- 12 and up
- COMIRB number
- 22-0644
- Compensation
- Yes
Overview
VALIANT is a clinical research study evaluating the safety and effectiveness of an investigational medication in young people and adults with C3G (primary C3 glomerulopathy) or IC-MPGN (immune complex membranoproliferative glomerulonephritis).
Contact us
For more information contact Kati.Dugan@childrenscolorado.org